Business Insights
Diagnostic Technologies
Diseases
Point-of-Care Testing
Research & Development
Sign In
About Us
Conferences
Videos
Webinars
Media & Press
Whitepapers
Advertising
Site Map
2023
March
16
Cue Health Q4 revenues decline 24% as firm expands, diversifies POC test menu
Genetic causes identified for three rare diseases
Week in Review: FDA warns about Janssen COVID-19 vaccine | BD nabs green light for molecular STI panel | Lab co-owner indicted for COVID-19 testing fraud
Researchers in study validate test to identify newborns with homocystinuria, a rare inherited disease
Becton Dickinson nabs FDA clearance for infectious vaginitis molecular test
Page 1 of 1